Maryam Vasefi

731 total citations
25 papers, 539 citations indexed

About

Maryam Vasefi is a scholar working on Physiology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Maryam Vasefi has authored 25 papers receiving a total of 539 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Physiology, 9 papers in Cellular and Molecular Neuroscience and 5 papers in Molecular Biology. Recurrent topics in Maryam Vasefi's work include Alzheimer's disease research and treatments (6 papers), Neuroscience and Neuropharmacology Research (4 papers) and Receptor Mechanisms and Signaling (4 papers). Maryam Vasefi is often cited by papers focused on Alzheimer's disease research and treatments (6 papers), Neuroscience and Neuropharmacology Research (4 papers) and Receptor Mechanisms and Signaling (4 papers). Maryam Vasefi collaborates with scholars based in Canada, United States and Egypt. Maryam Vasefi's co-authors include Michael A. Beazely, Stephen S. G. Ferguson, John J. Heikkila, Hymie Anisman, Alison Brown, Robyn J. McQuaid, Tarek Mohamed, Praveen P. N. Rao, Alison Hamilton and Khaled S. Abd‐Elrahman and has published in prestigious journals such as PLoS ONE, Neuroscience and Social Science & Medicine.

In The Last Decade

Maryam Vasefi

25 papers receiving 530 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maryam Vasefi Canada 13 199 182 151 116 53 25 539
F. Vercauteren Canada 12 217 1.1× 243 1.3× 308 2.0× 67 0.6× 40 0.8× 16 692
Yoshimasa Yamaguchi Japan 12 132 0.7× 225 1.2× 151 1.0× 117 1.0× 16 0.3× 26 549
Л. Ф. Нуруллин Russia 13 200 1.0× 267 1.5× 77 0.5× 120 1.0× 62 1.2× 56 524
Rafael González‐Cano Spain 16 326 1.6× 472 2.6× 336 2.2× 85 0.7× 12 0.2× 32 808
Ross Jeggo United Kingdom 15 153 0.8× 142 0.8× 173 1.1× 95 0.8× 51 1.0× 24 445
Perrine Busquet United States 9 260 1.3× 328 1.8× 72 0.5× 107 0.9× 35 0.7× 9 543
Victoria García‐Morales Spain 8 94 0.5× 162 0.9× 141 0.9× 101 0.9× 31 0.6× 17 432
Maria Rosaria Tropea Italy 12 179 0.9× 220 1.2× 320 2.1× 156 1.3× 42 0.8× 16 602
Guillermo Moya‐Alvarado Chile 10 185 0.9× 180 1.0× 111 0.7× 47 0.4× 17 0.3× 15 475
Cristina Martins-Silva Brazil 13 200 1.0× 158 0.9× 136 0.9× 80 0.7× 4 0.1× 22 515

Countries citing papers authored by Maryam Vasefi

Since Specialization
Citations

This map shows the geographic impact of Maryam Vasefi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maryam Vasefi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maryam Vasefi more than expected).

Fields of papers citing papers by Maryam Vasefi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maryam Vasefi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maryam Vasefi. The network helps show where Maryam Vasefi may publish in the future.

Co-authorship network of co-authors of Maryam Vasefi

This figure shows the co-authorship network connecting the top 25 collaborators of Maryam Vasefi. A scholar is included among the top collaborators of Maryam Vasefi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maryam Vasefi. Maryam Vasefi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hassler, Shayne, et al.. (2025). CBD and the 5-HT1A receptor: A medicinal and pharmacological review. Biochemical Pharmacology. 233. 116742–116742. 5 indexed citations
2.
Vasefi, Maryam, et al.. (2025). Natural disaster-induced dementia and cognitive decline: A meta-analysis and systematic review. Social Science & Medicine. 371. 117898–117898. 1 indexed citations
4.
Sarfraz, Zouina, et al.. (2024). Impact of socioeconomic status on cancer care in Southeast Texas: a retrospective population-based cohort study. Baylor University Medical Center Proceedings. 37(5). 782–793. 3 indexed citations
5.
Vasefi, Maryam, et al.. (2023). Polyherbal and Multimodal Treatments: Kaempferol- and Quercetin-Rich Herbs Alleviate Symptoms of Alzheimer’s Disease. Biology. 12(11). 1453–1453. 29 indexed citations
6.
Vasefi, Maryam, et al.. (2022). An “Instantaneous” Response of a Human Visual System to Hue: An EEG-Based Study. Sensors. 22(21). 8484–8484. 1 indexed citations
7.
Vasefi, Maryam, et al.. (2021). Cannabidiol and the corticoraphe circuit in post-traumatic stress disorder. IBRO Neuroscience Reports. 11. 88–102. 5 indexed citations
8.
Vasefi, Maryam, et al.. (2020). Environmental toxins and Alzheimer's disease progression. Neurochemistry International. 141. 104852–104852. 49 indexed citations
9.
Liu, Hui, Maryam Vasefi, Youngjik Choi, et al.. (2018). Amyloid-β Inhibits PDGFβ Receptor Activation and Prevents PDGF-BBInduced Neuroprotection. Current Alzheimer Research. 15(7). 618–627. 8 indexed citations
10.
Abd‐Elrahman, Khaled S., Alison Hamilton, Maryam Vasefi, & Stephen S. G. Ferguson. (2018). Autophagy is increased following either pharmacological or genetic silencing of mGluR5 signaling in Alzheimer’s disease mouse models. Molecular Brain. 11(1). 19–19. 40 indexed citations
11.
Munther, Michael, et al.. (2018). Microfabricated Biomimetic placoid Scale-Inspired surfaces for antifouling applications. Applied Surface Science. 453. 166–172. 50 indexed citations
12.
Brown, Alison, et al.. (2016). Chronic Pharmacological mGluR5 Inhibition Prevents Cognitive Impairment and Reduces Pathogenesis in an Alzheimer Disease Mouse Model. Cell Reports. 15(9). 1859–1865. 95 indexed citations
13.
Vasefi, Maryam, et al.. (2015). Fluoxetine-induced transactivation of the platelet-derived growth factor type β receptor reveals a novel heterologous desensitization process. Molecular and Cellular Neuroscience. 65. 45–51. 6 indexed citations
15.
Vasefi, Maryam, et al.. (2014). 5-HT7 receptor activation promotes an increase in TrkB receptor expression and phosphorylation. Frontiers in Behavioral Neuroscience. 8. 391–391. 27 indexed citations
17.
Vasefi, Maryam, et al.. (2013). 5‐Hydroxytryptamine type 7 receptor neuroprotection against NMDA‐induced excitotoxicity is PDGFβ receptor dependent. Journal of Neurochemistry. 125(1). 26–36. 28 indexed citations
18.
Vasefi, Maryam, et al.. (2012). Activation of 5-HT7 receptors increases neuronal platelet-derived growth factor β receptor expression. Neuroscience Letters. 511(2). 65–69. 14 indexed citations
19.
Vasefi, Maryam, et al.. (2012). 5-HT1A receptors transactivate the platelet-derived growth factor receptor type beta in neuronal cells. Cellular Signalling. 25(1). 133–143. 16 indexed citations
20.
Mohamed, Tarek, et al.. (2012). Development and evaluation of multifunctional agents for potential treatment of Alzheimer’s disease: Application to a pyrimidine-2,4-diamine template. Bioorganic & Medicinal Chemistry Letters. 22(14). 4707–4712. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026